Solvay SA
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
465 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
January 25, 2013 today
Open positions
No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.
Get the moves on Solvay SA by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| July 24, 2013 | Marshall Wace LLP | 0.59% | July 31, 2013 |
| June 27, 2013 | Marshall Wace LLP | 0.55% | July 24, 2013 |
| June 17, 2013 | Adage Capital Management L.P. | 0.59% | July 3, 2013 |
| May 24, 2013 | Adage Capital Management L.P. | 0.69% | June 17, 2013 |
| May 22, 2013 | Marshall Wace LLP | 0.52% | June 7, 2013 |
| May 8, 2013 | Marshall Wace LLP | 0.56% | May 13, 2013 |
| May 7, 2013 | Adage Capital Management L.P. | 0.76% | May 24, 2013 |
| May 7, 2013 | Citadel Europe LLP | 0.50% | May 31, 2013 |
| April 12, 2013 | Marshall Wace LLP | 0.60% | May 8, 2013 |
| April 9, 2013 | Adage Capital Management L.P. | 0.59% | May 7, 2013 |
| April 9, 2013 | Marshall Wace LLP | 0.52% | April 12, 2013 |
| April 3, 2013 | Adage Capital Management L.P. | 0.61% | April 9, 2013 |
| March 21, 2013 | Adage Capital Management L.P. | 0.58% | April 3, 2013 |
| March 12, 2013 | Adage Capital Management L.P. | 0.61% | March 21, 2013 |
| January 25, 2013 | Adage Capital Management L.P. | 0.51% | March 12, 2013 |
Download 465 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Belgium
- Solvay 1.39% of the capital sold short
- Umicore 1.20% of the capital sold short
- EVS 0.89% of the capital sold short
- D'Ieteren Group 0.79% of the capital sold short
- Syensqo 0.79% of the capital sold short
- Azelis 0.69% of the capital sold short
- Lotus Bakeries 0.69% of the capital sold short
- Sequana Medical 0.69% of the capital sold short
- Montea 0.58% of the capital sold short
- Melexis 0.51% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Solvay SA, source FSMA, data as at February 28, 2024, https://www.quivad.com/action/solvay-sa?page=10